Cann Group Limited (CNGGF)

USD 0.01

(66.67%)

Market Cap (In USD)

5.61 Million

Revenue (In USD)

15.37 Million

Net Income (In USD)

-51.24 Million

Avg. Volume

75.00

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
0.005-0.184
PE
-0.17
EPS
-0.06
Beta Value
1.36
ISIN
AU000000CAN2
CUSIP
-
CIK
-
Shares
561045000.0
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Ms. Jennifer Lee Pilcher AGIA, BBS, C.A.
Employee Count
-
Website
https://www.canngrouplimited.com
Ipo Date
2021-01-08
Details
Cann Group Limited engages in the breeding, cultivation, production, manufacturing, clinical evaluation, and supplying medicinal cannabis for sale and use within Australia and for overseas export markets. It licenses to undertake research and to cultivate cannabis for human medicinal and research purposes. The company was founded in 2014 and is based in Port Melbourne, Australia.